Tecfidera (dimethyl fumarate) is an oral medication used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome (CIS), relapsing-remitting disease (RRMS), and active secondary progressive disease. It works as a disease-modifying therapy (DMT) to reduce inflammation, decrease the number of flare-ups, and slow the progression of physical disability.
